Adverse Effects of Doxorubicin and Its Metabolic Product on Cardiac RyR2 and SERCA2A
Molecular Pharmacology - United States
doi 10.1124/mol.114.093849
Full Text
Open PDFAbstract
Available in full text
Date
August 8, 2014
Authors
Publisher
American Society for Pharmacology & Experimental Therapeutics (ASPET)